PharmD Signal

Deep dives, evidence grades, and clinical tools, all in one place.

Local AI Copilot Sharply Improves Pharmacist Prescription Screening

large language modelQwen3-14Bartificial intelligenceprescription reviewmedication safetyclinical decision supporthallucinationcrossover studyambulatory carepharmacy informatics Ambulatory Care / MTM

Background Information

LLMs boost accuracy and privacy in outpatient prescription review.

Locally deployed large language models (LLMs) can enhance outpatient prescription review accuracy while ensuring data privacy in hospitals. Human-AI collaboration improved review accuracy to 97.2% compared to 82.6% unaided, and reduced review time by approximately 51.9%. This study demonstrates the utility of LLMs in improving prescription accuracy and efficiency without external data transfer, which is crucial for privacy. Locally deployed LLMs significantly enhance outpatient prescription review accuracy while maintaining data privacy.

📊 Deep Analysis Available
Subscribers get the full breakdown: study design, outcomes, pharmacist implications, clinical pearls, GRADE evidence grade, and a downloadable PDF report.
Subscribe for Full Access →

Authors: Liu Z, Ding Y, Chen J, Yan Z, Cheng X, Zhou W, Fu P, Wang Z

Citation: Liu Z, Ding Y, Chen J, et al. Locally Deployed Large Language Models for AI-Assisted Outpatient Prescription Review: Crossover Study. JMIR medical informatics. 2026;14:e97520. doi:10.2196/97520

Article Links: PubMed · Journal / DOI

🎓
Reviewed by a licensed pharmacist
Every analysis is reviewed and approved by a licensed pharmacist before publication, ensuring clinical accuracy and relevance.
Accurate and up-to-date information is our highest priority.
If you spot an error, please suggest a correction. If there is a topic you want covered, tell us and we will look at it.
Thanks for the feedback!
🔒
Deep Analysis: Subscribers Only
Subscribers receive access to a complete clinical analysis, available online and as a downloadable PDF.
Executive Summary
Study Design
Patient Population
Primary Outcomes
Secondary Outcomes & Safety Profile
Pharmacist Implications
Clinical Pearls
Limitations
Controversies & Evidence Gaps
Cost & Logistics
Want the full analysis?

Subscribe to PharmD Signal for unrestricted access to every deep analysis, plus PDF reports, GRADE evidence grades, and pharmacist implications for every article we publish.

Become a Subscriber →